A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4245 (2006.01) A61P 3/10 (2006.01) A61P 7/00 (2006.01) A61P 9/00 (2006.01) A61P 11/00 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2603402
The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro- phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.
La présente invention se rapporte à des doses et à des posologies spécifiques d'un composé d'acide 1,2,4-oxadiazole benzoïque, qui permettent de traiter ou de prévenir des maladies associées à des mutations non-sens. L'invention a trait en particulier à des doses et à des posologies spécifiques destinées à l'utilisation d'acide 3-[5-(2-fluoro-phényl)-[1,2,4]oxadiazol-3-yl]-benzoïque chez des mammifères atteints de maladies associées à des mutations non-sens.
Hirawat Samit
Miller Langdon
Osler Hoskin & Harcourt Llp
Ptc Therapeutics Inc.
LandOfFree
Compositions of an orally active 1,2,4-oxadiazole for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of an orally active 1,2,4-oxadiazole for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of an orally active 1,2,4-oxadiazole for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1395341